Senior Program Officer
Bill & Melinda Gates Foundation
Ping obtained his BS in Pharmacy from Beijing Medical University in China in 1994, and his PhD in Pharmaceutics from University of Washington in Seattle, WA, USA in 2002. Since then, Ping worked as a DMPK scientist at Pfizer in La Jolla CA (2002-2005), a pharmacokineticist at Sonus Pharmaceuticals in Seattle (2005-2007), a clinical pharmacologist at Amgen in Seattle (2008), and the Scientific Lead of PBPK (physiologically-based pharmacokinetic modeling) Program and Expert Pharmacologist at the Office of Clinical Pharmacology, US FDA in Silver Spring, MD (2008-2017). At FDA, Ping led review of PBPK submissions in IND/NDA/BLAs. He was responsible for the review of more than 200 PBPK analyses in IND, NDA, and BLA submissions. More than 40 of these submissions had simulation results being used in product labels to support optimal use of the drugs. He championed PBPK regulatory research and engineered policies around PBPK, including authoring the agency’s first PBPK guidance (2016) and implementing evidence-based PBPK approaches in FDA’s drug-drug interaction guidances (2017). During his tenure at FDA, Ping served as liaison to coordinate regulatory applications of PBPK in addressing drug interaction and other clinical pharmacology issues with EMA, MHRA, and PMDA. In June 2017, Ping joined the Bill and Melinda Gates Foundation in Seattle, WA as a Senior Program Officer of Quantitative Sciences, where he applies pharmacology concepts and manages Model-informed Drug development (MiDD) efforts in programs funded by the foundation to academic centers, product development partners, and regulatory agencies around the world. He received many awards, published more than 80 peer-reviewed articles. He is currently an associate editor for the journal Clinical Pharmacology and Therapeutics-Pharmacometrics and Systems Pharmacology.
Disclosure information not submitted.
Thursday, March 17, 2022
12:15 PM – 1:15 PM ET
Monday, April 25, 2022
8:00 AM – 1:30 PM ET
Friday, September 16, 2022
10:00 AM – 4:00 PM ET
.png)